Leung et al. examined gene expression levels of ACE2 in the airways of individuals with and without COPD and found that active cigarette smoking and COPD upregulate ACE2 expression in lower airways and could contribute to the difference in disease burden observed among COVID-19 patients [77]. The gene discussed is ACE2; the disease is COVID-19.